Cai Pei-Biao, Dou Yi-Biao, Lin Chuang-Jian, Wen Guan-Nan, Chen Hai-Bo, Wang Chuang-Ming
Shantou Hospital of Traditional Chinese Medicine, Shantou 515041, Guangdong, China.
Beijing Hospital of Tibetan Medicine of China Tibetology Research Center, Beijing 100029, China.
Zhongguo Gu Shang. 2025 Jun 25;38(6):566-71. doi: 10.12200/j.issn.1003-0034.20250505.
To explore short-term clinical efficacy of minimally invasive diagnosis and treatment system for hallux valgus in guiding the treatment of hallux valgus.
From March 2021 to November 2023, 68 patients (136 feet) with hallux valgus were treated under guidance of minimally invasive diagnosis and treatment system, including 12 males and 56 females;aged from 25 to 68 years old with an average of (42.5±8.5) years old, the course of disease ranged from 3.2 to 15.6 years with an average of (10.3±2.6) years. The changes of hallux valgus angle (HVA) and intermetatarsal angle (IMA), visual analog scale (VAS) and American Orthopaedic Foot Ankle Society (AOFAS) forefoot score were recorded and compared before operation and 12 months after operation.
Sixty-five patients (130 feet) were followed up for 12 to 15 months with an average of (13.8±0.5) months, 3 patients (6 feet) were not followed up as required. HVA and IMA improved from (35.5±3.5) ° and (12.5±2.0) ° before operation to (10.5±2.5) ° and (8.5±1.5) °12 months after operation, respectively, with statistically significant differences (<0.05);VAS decreased from (5.5±1.2) before operation to (1.2±0.5) at 12 months after operation, and the difference was statistically significant (<0.05);AOFAS forefoot score increased from (50.6±5.1) before operation to (93.8±5.6) at 12 months after operation, with a statistically significant difference (<0.05). Among them, 102 feet were got excellent result, 24 feet good, and 4 feet fair. Two patients were developed calf intermuscular vein thrombosis, and were cured after 3 months of symptomatic treatment.
Under the guidance of minimally invasive diagnosis and treatment system for hallux valgus, the treatment of HV could obviously improve HVA and IMA, and significantly alleviate pain symptoms, and accelerate functional recovery.
探讨拇外翻微创诊疗系统在指导拇外翻治疗中的短期临床疗效。
2021年3月至2023年11月,68例(136足)拇外翻患者在拇外翻微创诊疗系统指导下接受治疗,其中男性12例,女性56例;年龄25~68岁,平均(42.5±8.5)岁,病程3.2~15.6年,平均(10.3±2.6)年。记录并比较术前及术后12个月拇外翻角(HVA)、第1~2跖骨间角(IMA)、视觉模拟评分(VAS)及美国足踝外科协会(AOFAS)前足评分的变化。
65例(130足)获12~15个月随访,平均(13.8±0.5)个月,3例(6足)未按要求随访。HVA和IMA分别由术前的(35.5±3.5)°和(12.5±2.0)°改善至术后12个月的(10.5±2.5)°和(8.5±1.5)°,差异有统计学意义(<0.05);VAS由术前的(5.5±1.2)降至术后12个月的(1.2±0.5),差异有统计学意义(<0.05);AOFAS前足评分由术前的(50.6±5.1)升至术后12个月的(93.8±5.6),差异有统计学意义(<0.05)。其中优102足,良24足,可4足。2例患者出现小腿肌间静脉血栓形成,经对症治疗3个月后治愈。
在拇外翻微创诊疗系统指导下治疗拇外翻,可明显改善HVA和IMA,显著缓解疼痛症状,加速功能恢复。